Patent ID: 6090831
Filing Date: 2000-07-18
Classification: A01N,C07D

Abstract:
A sulphonyloxadiazolone of the formula ##STR220## in which A represents a single bond or represents alkanediyl, alkenediyl, alkinediyl or a grouping --*O--CH.sub.2 --, --*O--CH.sub.2 --CH.sub.2 --, --*CH.sub.2 --O--, --*CH.sub.2 --O--CH.sub.2 --CH.sub.2 --, --*CH.sub.2 --S--, --*S--CH.sub.2 --, ##STR221## where the atom labeled by * is in each case attached to R.sup.1 and R.sup.3 represents hydrogen or an alkyl group,R.sup.1 represents hydrogen, an optionally substituted cycloalkyl group, an optionally substituted cycloalkenyl group, an optionally substituted aryl group or an optionally substituted heterocyclic group andR.sup.4 represents an optionally substituted alkyl group, an optionally substituted alkenyl group, a dialkylamino group, a nitro-substituted phenyl group which may also contain one or two further substituents, or represents optionally a substituted heterocyclic group, provided that R.sup.4 does not represent propyl when A represents a direct bond and R.sup.1 represents a 2,4,6-trimethyl-phenyl group.